Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT07032584
- Status
- Recruiting
Conditions
- Androgen Deprivation Therapy
- Metastatic Prostate Cancer
- Prostate Cancer
Eligibility Criteria
- Sex
- MALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Telerehabilitation Intervention — OTHERTheTelerehabilitation Intervention (TR) group utilizes a touchscreen tablet equipped with a computer-guided rehabilitation program that provides ongoing support and feedback for home-based rehabilitation.
Study Details
People with prostate cancer may have a decreased quality of life due to the cancer itself and due to a lifesaving cancer treatment. Physical therapy, including regular exercise, helps patients with cancer to reduce disease symptoms and improve their quality of life. However, cancer rehabilitation programs in rural areas are not readily available and may require constant travel and significant financial resources, which may limit access to these services on a continuous basis. Technology can allow patients residing in rural areas to exercise at home under the supervision of their rehabilitation team. However, it is unclear how effective this approach is. This research team will conduct a clinical trial in which half of the randomly chosen participants receiving hormonal prostate cancer therapy will use this new technology to exercise at home. Another half - will exercise at home without this new technology. After six months, the study will compare the quality of life and cancer symptoms in these two groups. The investigators hope that this study will demonstrate that the patients who were helped by the new technology to exercise at home will have better fitness, fewer symptoms, and better quality of life. If the study demonstrates this in this project, other patients with cancer residing in rural areas will be able to take advantage of this technology. This approach can be extended to people with different diseases who have difficulties accessing medical care in rural areas to undergo required physical, cognitive, and occupational rehabilitation, and improve their quality of life.
Key Dates
- Start date
- May 27, 2025
- Status verified
- Jul 2025
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 74 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Telerehabilitation InterventionParticipants in the Telerehabilitation Intervention group (TR) will receive a comprehensive baseline examination conducted by the blinded assessment team. They will also be evaluated by the clinical PT who will prescribe an individualized exercise plan and train them how to perform the exercises. Patients will be mailed exercise equipment (portable bike, elastic bands, pulse oximeter, and activity tracker) with the necessary instructions. Additionally, the TR group will also receive a touchscreen tablet for computer-mediated support in following their individualized exercise plans at their homes daily. The tablet will contain multimedia instructional materials on how to set up and use the telerehab unit.
- Other: Best Available CareParticipants in the Best Available Care (BAC) group will receive a comprehensive baseline examination conducted by the blinded assessment team. They will also be evaluated by the clinical PT who will prescribe an individualized exercise plan and train them how to perform the exercises. Patients will be mailed exercise equipment (portable bike, elastic bands, pulse oximeter, and activity tracker) with the necessary instructions.
Primary Outcome Measure
Functional Assessment of Cancer Therapy-Prostate (FACT-P) [ Time Frame: up to 6 months from baseline ]
Central Contacts
- Manish Kohli, MD801-646-4018
- Aileen Gabriel9782109782
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Utah Huntsman Cancer Institute | Salt Lake City | Utah | 84112 |
Find similar trials in Salt Lake City, UT
Related Studies
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPHASE1 · Recruiting · Amgen · Duarte, California
- Study of ORIC-944 in Patients With Metastatic Prostate CancerPHASE1 · Recruiting · ORIC Pharmaceuticals · Colorado Springs, Colorado
- Pembro With Radiation With or Without OlaparibPHASE2 · Recruiting · Zin W Myint · Lexington, Kentucky
- Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyPHASE3 · Recruiting · Clarity Pharmaceuticals Ltd · Birmingham, Alabama